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1. Introduction 
A parallelism has been shown between the 
anticonvulsive effect and an increase in the cerebral 
GABA level after in vivo administration of some 
branched chain fatty acids such as n-dipropylacetate 
[ 1,2] . It has also been shown that these compounds 
improve conditioned behaviour [3] . It was later 
demonstrated that these compounds are competitive 
inhibitors of rat and mouse cerebal GABA-T**, thus 
probably explaining these effects [4]. This has 
stimulated interest in the search for non toxic 
compounds, slowly metabolised by the body, yet 
being powerful inhibitors of cerebral GABA-T. In 
order to test these compounds with human therapy in 
mind, it seemed pertinent to use GABA-T from human 
brain. We thus proceeded to purify this enzyme guided 
by the methods we employed for purification of GABA-T 
from rat brain [ 51. This human GABA-T preparation 
will also enable a comparison to be made with brain 
GABA-T from other species, in particular that of the 
mouse [6] and that of the rat [5] . 
2. Materials and methods 
The purification was made from a human brain 
removed 4 hr after death. After removal of the 
meninges, the cerebral trunk, the cerebellum and the 
* This work is part of C.C.‘s thesis. 
**Abbreviations: GABA-T: 4-Aminibutyrate 2-Ketoglutarate 
Transaminase (EC 2.6.1.19), AET: 2-Aminoethylisothiou- 
ronium Bromide Hydrobromide, PLP: Pyridoxal Phosphate. 
North-Holland Publishing Company - Amsterdam 
corpus callosum, the remaining 980 g of cerebral 
material was homogenised in fractions in 6 1 of 0.25 M 
sucrose containing 1 mM AET. All these operations 
and those which followed were performed at 4’C. 
2.1. Purification 
The homogenate was centrifuged at 1000 g for 15 
min to precipitate the cellular debris and nuclei, then 
the supernatant was centrifuged at 6000 g for 30 min 
to precipitate the mitochondria. The pellet was washed 
by resuspension in 0.25 M sucrose, then recentrifuged. 
The mitochondrial pellet was lysed for 30 min in 2 1 
of water containing 1 mM AET and 0.1 mM EDTA. 
After centrifugation of the suspension at 50 000 g 
for 2.5 hr, the resultant pellet was frozen at -2O”C, 
thawed and homogeneised in a Waring blendor with 2 1 
of water containing 1 mM AET, 0.1 mM EDTA and 
10 mg/l PLP. The suspension was frozen, then thawed, 
and after centrifugation at 105 000 g for 90 min, the 
supernatant (1240 ml) was used as the source of GABA-T 
The proteins were precipitated by ammonium 
sulphate addition at 4’C, the pH maintained at 7.2. 
The fraction precipitating between 45 and 67% 
ammonium sulphate saturation was redissolved in 75 ml 
of 2 mM phosphate buffer pH 7.2 containing 1 mM 
AET, 0.1 mM EDTA and 10 mg/l PLP. All further 
operations were conducted at this pH and with these 
concentrations of protectors. This solution was divided 
into 4 parts, each of which was successively chromato- 
graphed on a Sephadex G-200 column under the same 
conditions as those described for the rat enzyme [ 51. 
All the enzyme eluted from the four G-200 runs was 
absorbed on a DEAE cellulose column and eluted with 
a linear gradient of phosphate buffer pH 7.2 between 
2 and 50 mM. The enzyme eluted from this column 
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was absorbed on a DEAE Sephadex column and eluted 
with a linear gradient of phosphate pH 7.2 between 10 
and 200 mM. 
On these various supports, the human enzyme 
behaves in the same way as the rat enzyme [5]. 
2.2. Determination of enzyme activity 
Two methods were used: (a) Salvador Alber’s 
method with certain modifications [S] was used to 
identify the enzyme activity in the column eluates 
and to establish the pH optimum and temperature 
of maximum activity. (b) The method of Waksman 
and Roberts was used [7] to determine the K,,, . 
Here, the [14C1] glutamate formed [14C1] cu-keto- 
glutarate was separated via a Dowex column 50 X 8, 
H+ form and the radioactivity measured by liquid 
scintillation counting. 
2.3. Protein determination 
For the stages before column chromatography, 
Lowry’s method was used, for later stages, owing to the 
low protein concentrations and high level of interfering 
substances (AET, PLP) the determinations were 
performed by densitometry of the protein bands stained 
with Coomassie Blue R 250 after electrophoresis on 
polyacrylamide gels. Protein standards were run under 
the same conditions using BSA. The results from this 
method were in agreement with those obtained by 
intergration of the o-amino acid peaks from the 
hydrolysed proteins on a Technicon amino acid analyser. 
2 A. Disc elec trophoresis 
7.5% Polyacrylamide gels were used according to the 
technique of Joivin et al. [8] . The protein bands were 
stained with Coomassie Blue R 250. 
2.5. Determination ofpH optimum 
Tris-HCl buffers, 0.3 M pH 7.4 to 9.4 containing 
GABA 50 mM, cr-ketoglutarate 5 mM and the usual 
protectors (AET, EDTA, PLP) were used. The enzyme 
activity was measured during the first 30 min during 
which the reaction was linear with time. 
2.6. Temperature/activity relationship 
The above buffer was used though at the optimum 
pH of 8.6. The enzyme activity was measured during 
the first 30 min incubation at temperatures from O- 
7o”c. 
2.7. Determinations of apparent Km’s 
The rate of formation of [ l4 Cr ] glutamate was 
measured during the first 30 min incubation at 37°C 
in 0.3 M Tris-HCl buffer at pH 8.6. 
3. Results 
3.1. Purification 
Under the above conditions, 80 /Ig of enzyme 
purified 1400-fold was obtained from one human 
brain. The yield of enzyme units was 0.14% (table 1). 
3.2. Electrophoresis 
A single band was obtained on 7.5% PAA gels, at 
pH 8.9 (fig. 1) 40 (ug of protein was put on the gel. 
The densitometer trace from the stained gel suggests 
Table 1 
Purification of GABA-Transaminase from human brain 
Total 
proteins 
(mg) 
Yield 
% 
Specific Total Activity 
activity Purification activity yield 
pmole/min/mg Hmole/min % 
Sucrose homogenate 87 100 100 27 X 10“ 1 227 100 
Crude mitochondrial 
extract 205 2.3 53 x lo-$ 19 10.9 4.8 
Ammonium sulphate 37 0.42 86 X lo-’ 32 3.17 1.4 
Sephadex G-200 1.5 2 X lo-’ 0.65 230 0.975 0.42 
DEAE Cellulose 0.378 4 X lo-’ 2.3 880 0.87 0.38 
DEAE Sephadex 0.083 1 X lo-’ 4 1440 0.32 0.14 
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Fig. 1. Gel electrophoresis on 7.5% polyacrylamide of 
purified GABA transaminase. Top: Photography. Bottom: 
Densitometry. S: Start. F: Bromophenol Blue front. 
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Fig. 2. Specific activity as a function of pH. Specific ac- 
tivity expressed as percent of maximum specific activity. 
RSA: Relative specific activity. 
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Fig. 3. Specific activity as a function of temperature. 
Specific activity expressed as percent of maximum specific 
activity. RSA: Relative specific activity. 
a purity of 80% if one considers that the shoulder on 
the recording is due to a contamination. 
3.3.pHoptimum 
The enzyme shows maximum activity at pH 8.6. 
However, the activity/pH curve shows a shoulder at 
pH 8. (fig.2). 
3.4. Temperature/activity relationship 
Under the conditions of the experiments, maximum 
enzyme activity is seen at 50°C. The reaction rate 
decreases lowly between 50’ and 60°C, and very 
rapidly at higher temperatures. (fig. 3). 
3.5. Apparent K,,, ‘s (jig. 4) 
(a) For GABA: with cr-ketoglutarate at the concen- 
tration of 0.3 mM the apparent K,,, for GABA is 
4~10-~ M. 
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Fig. 4. Graphic determination of Km (apparent) of GABA and or-ketoglutarate. Lineweaver-Burk plot. Abcissa: reciprocal of 
concentration (mM) of GABA or o-ketoglutarate. Ordinate: reciprocal of reaction rate &mole/In). 
(b) For cw-ketoghrtarate: with 10 mM GABA, the 
apparent Km for cu-ketoghrtarate is 1 mM. 
4. Discussion 
Because of the inevitable delays in obtaining a 
human brain, the initial specific activity of the 
homogenate is relatively low. It is possible that some 
of the enzyme is denatured yet is isolated together 
with the active enzyme during purification hence 
lowering the final specific activity. Nevertheless, 
the specific activity of the purified enzyme approaches 
that of the mouse brain enzyme prepared by Roberts 
et al. (specific activity of 300 nmole/hr/mg) but is 
much lower than that of the rat brain enzyme recently 
purified in our laboratory, (specific activity 600 
mnoles/hr/mg) [5]. The purification of the human 
enzyme was estimated as 80% when taking the shoulder 
of the densitometer trace from PAA gels as a contami- 
nant. However, a similar shoulder is seen on the pH/ 
activity curve, suggesting the possibility of isoenzymes 
with pH optima 8 and 8.6. It is thus possible that much 
of the 20% impurity calculated from the densitometric 
trace consists of the isoenzyme with the pH optimum of 
8. This isoenzyme could thus be similar to that obtained 
from mouse brain by Roberts et al. [6]. The enzyme 
remains active for about an hour at 60°C hence it is 
more thermostable than the enzyme isolated from 
mouse and rat brain. The apparent Km’s measured under 
the conditions described above are very similar to those 
measured under the same conditions for the rat enzyme 
(K,,, GABA: human 4.10m4 M, rat 3-10W4; K,,, cY-keto- 
glutarate: human 1.10e3 M, rat 1.2.10-3 M). 
Currently, the reality of the presence of isoenzyme 
is under investigation, with the view, if indeed there are 
isoenzymes, to isolate the pure species. 
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